Ana Alice de Aquino

Ana Alice de Aquino

Auto-generated profile, based on publicly available information

Ana Alice de Aquino

Postgraduate Program in Virology, Evandro Chagas Institute, 67030-000, Ananindeua, PA, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2021 in Anti-Infective Agents
Verified
Journal Article
Closed access
PDF file
MAMarlyanne Maria Carvalho Silva de Almeida
Marlyanne Maria Carvalho Silva de Almeida
RJRenato Ferreira de Almeida Júnior
Renato Ferreira de Almeida Júnior
AAAna Alice de Aquino
Ana Alice de Aquino
LPLívia de Lourdes Pinto
Lívia de Lourdes Pinto
PMPaula Renata Lima Machado
Paula Renata Lima Machado
GAGiulianna Paiva Viana de Andrade
Giulianna Paiva Viana de Andrade
Background: According to the World Health Organization (WHO), two-fifths of the world population is at risk of infection by DENV. There are no safe and effective vaccines established. Sulfated glycosaminoglycans such as heparin, used as anticoagulants, inhibit the initial step of dengue viral replication. Recently, an isolated heparin analogue Goniopsis cruentata (cCTH) has presented a low anticoagulant effect with reduced bleeding risk. Methods : The antiviral activity of cCTH and heparin compounds against DENV-2 in Vero cell culture was determined by quantitative RT-PCR (qRT-PCR) and titration. For this, four trials were carried out: treatment of the cells for 2 h before viral inoculation, concomitant viral inoculation treatment, treatment after viral inoculation and virucidal assay. Subsequently, the culture supernatants were collected for periods of 24, 48 and 72 h. Results: Our results demonstrated that cCTH and heparin showed antiviral activity against DENV-2. Conclusion : These data suggest that both compounds prevented viral replication in cultured Vero cells.